News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication May 29, 2023 Standardizing Scoring Conventions for Crohn’s Disease Endoscopy: An International RAND/UCLA Appropriateness Study Read Now
Publication May 29, 2023 Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPT™ tubes Read Now
Publication May 29, 2023 Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis Read Now
Publication May 1, 2023 Advanced Combination Treatment With Biologic Agents and Novel Small Molecule Drugs for Inflammatory Bowel Disease Read Now
Publication Apr 24, 2023 Real-World multicentre observational study with Pop-PK modelling to evaluate the exposure-response relationship of vedolizumab in IBD Read Now
Publication Apr 17, 2023 ATRC Review: IL-12 and IL-23 pathway inhibition in inflammatory bowel disease Read Now
